Feedback / Questions
lorigerlimab (MGD019) - MacroGenics
vobramitamab duocarmazine (MGC018) - MacroGenics
https://www.globenewswire.com/news-release/2023/11/06/2774465/0/en/MacroGenics-Provides-Update-on-Corporate-Progress-and-Third-Quarter-2023-Financial-Results.html
Nov 6, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next